S109: ACTIVATION OF PYRUVATE KINASE-R WITH ETAVOPIVAT (FT-4202) IS WELL TOLERATED, IMPROVES ANEMIA, AND DECREASES INTRAVASCULAR HEMOLYSIS IN PATIENTS WITH SICKLE CELL DISEASE TREATED FOR UP TO 12 WEEKS
| Autor: | M Telen, S Saraf, K Cruz, M Idowu, T Kalfa, I Osunkwo, R Hagar, J Geib, S Forsyth, P Schroeder, E Wu, P Kelly, R Brown |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | HemaSphere, Vol 6, Pp 5-5 (2022) |
| Druh dokumentu: | article |
| ISSN: | 2572-9241 00008214 |
| DOI: | 10.1097/01.HS9.0000821404.03661.11 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text